KPJ Healthcare Bhd.(MY:5878)
RM2.69-0.01 (-0.37%)
MY:5878
KPJ Healthcare Bhd. financials statements
RM2.69
At close:-0.01 (-0.37%)
KPJ Healthcare Bhd. (5878) Ratios
KPJ Healthcare Bhd. Ratios
MY:5878's free cash flow for Q2 2026 was RM193.28M. For the 2026 fiscal year, MY:5878's free cash flow was decreased by RM-47.68M and operating cash flow was RM240.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 1.24 | 1.19 | 0.88 | 0.77 |
| Quick Ratio | 1.44 | 1.18 | 1.14 | 0.84 | 0.74 |
| Cash Ratio | 0.76 | 0.47 | 0.48 | 0.28 | 0.18 |
| Solvency Ratio | 0.13 | 0.14 | 0.11 | 0.09 | 0.07 |
| Operating Cash Flow Ratio | 0.66 | 0.65 | 0.47 | 0.27 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 3.56 | 2.73 | 1.24 | 0.56 | 0.49 |
| Net Current Asset Value | RM -3.04B | RM -3.06B | RM -3.05B | RM -3.17B | RM -2.72B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.49 | 0.50 | 0.53 | 0.54 | 0.51 |
| Debt-to-Equity Ratio | 1.44 | 1.45 | 1.60 | 1.68 | 1.47 |
| Debt-to-Capital Ratio | 0.59 | 0.59 | 0.62 | 0.63 | 0.60 |
| Long-Term Debt-to-Capital Ratio | 0.32 | 0.34 | 0.36 | 0.31 | 0.30 |
| Financial Leverage Ratio | 2.92 | 2.92 | 3.04 | 3.14 | 2.90 |
| Debt Service Coverage Ratio | 2.06 | 1.65 | 1.00 | 0.61 | 0.45 |
| Interest Coverage Ratio | 3.45 | 3.30 | 2.52 | 2.04 | 1.48 |
| Debt to Market Cap | 0.13 | 0.15 | 0.30 | 0.42 | 0.37 |
| Interest Debt Per Share | 0.95 | 0.89 | 0.92 | 0.91 | 0.77 |
| Net Debt to EBITDA | 2.77 | 3.03 | 3.89 | 4.74 | 5.62 |
| Profitability Margins | |||||
| Gross Profit Margin | 44.57% | 44.75% | 41.88% | 40.04% | 35.79% |
| EBIT Margin | 17.79% | 18.56% | 15.77% | 14.53% | 10.06% |
| EBITDA Margin | 25.09% | 25.75% | 23.70% | 23.69% | 19.34% |
| Operating Profit Margin | 15.74% | 16.56% | 15.09% | 13.67% | 9.45% |
| Pretax Profit Margin | 13.37% | 13.68% | 9.78% | 9.02% | 4.40% |
| Net Profit Margin | 8.59% | 9.02% | 7.70% | 5.72% | 1.94% |
| Continuous Operations Profit Margin | 9.43% | 9.30% | 7.48% | 5.28% | 1.77% |
| Net Income Per EBT | 64.27% | 65.94% | 78.81% | 63.36% | 44.15% |
| EBT Per EBIT | 84.92% | 82.61% | 64.79% | 66.02% | 46.55% |
| Return on Assets (ROA) | 4.55% | 4.78% | 3.64% | 2.39% | 0.82% |
| Return on Equity (ROE) | 13.27% | 13.95% | 11.05% | 7.50% | 2.39% |
| Return on Capital Employed (ROCE) | 9.96% | 10.64% | 8.83% | 7.50% | 5.39% |
| Return on Invested Capital (ROIC) | 6.71% | 6.81% | 6.14% | 4.65% | 2.56% |
| Return on Tangible Assets | 4.67% | 4.91% | 3.74% | 2.46% | 0.86% |
| Earnings Yield | 3.11% | 3.34% | 4.25% | 3.81% | 1.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.78 | 4.97 | 4.55 | 3.85 | 4.55 |
| Payables Turnover | 2.62 | 2.62 | 9.56 | 7.34 | 7.19 |
| Inventory Turnover | 23.62 | 27.09 | 27.21 | 26.58 | 31.38 |
| Fixed Asset Turnover | 0.89 | 0.85 | 0.78 | 0.67 | 0.69 |
| Asset Turnover | 0.53 | 0.53 | 0.47 | 0.42 | 0.42 |
| Working Capital Turnover Ratio | 8.62 | 13.65 | 104.75 | -10.37 | -10.04 |
| Cash Conversion Cycle | -47.36 | -52.62 | 55.48 | 58.87 | 41.05 |
| Days of Sales Outstanding | 76.32 | 73.38 | 80.23 | 94.88 | 80.17 |
| Days of Inventory Outstanding | 15.46 | 13.48 | 13.41 | 13.73 | 11.63 |
| Days of Payables Outstanding | 139.13 | 139.48 | 38.16 | 49.75 | 50.75 |
| Operating Cycle | 91.77 | 86.86 | 93.65 | 108.61 | 91.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.20 | 0.19 | 0.15 | 0.11 | 0.10 |
| Free Cash Flow Per Share | 0.14 | 0.11 | 0.10 | 0.05 | 0.05 |
| Dividend Paid and CapEx Coverage Ratio | 1.90 | 1.50 | 1.70 | 1.43 | 1.71 |
| Capital Expenditure Coverage Ratio | 3.20 | 2.21 | 2.73 | 1.96 | 1.90 |
| Operating Cash Flow Coverage Ratio | 0.22 | 0.23 | 0.17 | 0.12 | 0.13 |
| Operating Cash Flow to Sales Ratio | 0.20 | 0.22 | 0.19 | 0.16 | 0.16 |
| Free Cash Flow Yield | 5.05% | 4.36% | 6.73% | 5.14% | 4.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 32.14 | 29.93 | 23.51 | 26.23 | 93.28 |
| Price-to-Sales (P/S) Ratio | 2.76 | 2.70 | 1.81 | 1.50 | 1.81 |
| Price-to-Book (P/B) Ratio | 4.27 | 4.18 | 2.60 | 1.97 | 2.23 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 19.80 | 22.93 | 14.85 | 19.44 | 24.37 |
| Price-to-Operating Cash Flow Ratio | 13.61 | 12.56 | 9.42 | 9.54 | 11.56 |
| Price-to-Earnings Growth (PEG) Ratio | 10.44 | 0.87 | 0.41 | 0.12 | -1.73 |
| Enterprise Value Multiple | 13.78 | 13.53 | 11.53 | 11.08 | 15.00 |
| Enterprise Value | 14.73B | 13.66B | 9.34B | 7.67B | 7.62B |
| EV to EBITDA | 13.78 | 13.53 | 11.53 | 11.08 | 15.00 |
| EV to Sales | 3.46 | 3.48 | 2.73 | 2.63 | 2.90 |
| EV to Free Cash Flow | 24.78 | 29.54 | 22.40 | 33.99 | 38.99 |
| EV to Operating Cash Flow | 17.03 | 16.18 | 14.21 | 16.68 | 18.49 |
| Tangible Book Value Per Share | 0.64 | 0.58 | 0.53 | 0.49 | 0.47 |
| Shareholders’ Equity Per Share | 0.63 | 0.58 | 0.55 | 0.51 | 0.50 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.32 | 0.23 | 0.28 | 0.43 |
| Revenue Per Share | 0.97 | 0.90 | 0.78 | 0.67 | 0.61 |
| Net Income Per Share | 0.08 | 0.08 | 0.06 | 0.04 | 0.01 |
| Tax Burden | 0.64 | 0.66 | 0.79 | 0.63 | 0.44 |
| Interest Burden | 0.75 | 0.74 | 0.62 | 0.62 | 0.44 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.29 | 0.29 | 0.29 | 0.27 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 2.36 | 1.47 | 1.90 | 1.80 | 3.57 |
Currency in MYR
